You have not yet registered? Get your account for free.
Forgot Password? We will send you a reset link
09
Aug 24
Publication half-yearly financial report
14
Nov 24
Publication quarterly financial report (call-date Q3)
26
Jun 24
Annual General Meeting
May 24
Publication quarterly financial report (call-date Q1)
22
Mar 24
Publication annual financial report
Nov 23
10
Aug 23
07
Jun 23
11
May 23
30
Mar 23
18
Jan 23
Analysts’ Conference
29
Nov 22
Aug 22
01
Jun 22
12
May 22
Mar 22
Nov 21
Aug 21
02
Jun 21
17
May 21
16
Apr 21
Nov 20
13
Aug 20
Jun 20
May 20
31
Mar 20
Nov 19
Aug 19
May 19
28
Mar 19
Nov 18
Jul 18
May 18
08
Mar 18
Nov 17
Aug 17
May 17
16 July 2024
Eckert & Ziegler Again Increases Sales and Earnings Compared to Previous Year. Profit Forecast Raised for 2024.
12 July 2024
26 June 2024
Annual General Meeting of Eckert & Ziegler SE Approves Split-Off of Pentixapharm AG
25 June 2024
Eckert & Ziegler Subsidiary Pentixapharm Receives Encouraging FDA Feedback to Initiate Phase III Trial with PentixaFor as Radiopharmaceutical Diagnostic in Primary Aldosteronism
19 June 2024
Eckert & Ziegler and UJF Open State-of-the-Art Actinium-225 Production Facility
14 May 2024
Q1 statement / Q1 financial report 2024
3 May 2024
Jahresfinanzbericht 2023 (PDF)
Annual financial report 2023 (PDF)
Jahresfinanzbericht 2023 (ZIP)
19 April 2024
3 November 2011
Original-Research: Eckert & Ziegler Strahlen- und Medizintechnik AG (von BankM – Repräsentanz der biw Bank für Investments und Wertpapiere AG): Kaufen
5 August 2011
3 May 2011
11 April 2011
9 November 2010
Original-Research: Eckert & Ziegler Strahlen- und Medizintechnik AG (von BankM – Repräsentanz der biw Bank für Investments und Wertpapiere AG): Neutral
10 May 2010